Rigel Pharmaceuticals Inc
RIGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001034842
No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Rigel Pharmaceuticals Inc as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 91
- −26 vs. Q1 2024
- Shares held
- 10.4M
- −708.8K (−6.4%) vs. Q1 2024Converted for a 1-for-10 split
- Total value
- $85.4M
- −$78.9M (−48.0%) vs. Q1 2024
- New holders
- 13
- 39 more added
- Sold out
- 39
- 23 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 155 | $640.4M |
| Q1 2026 | 159 | $432.8M |
| Q4 2025 | 194 | $690.5M |
| Q3 2025 | 169 | $425.6M |
| Q2 2025 | 126 | $260.2M |
| Q1 2025 | 123 | $250.2M |
| Q4 2024 | 122 | $203.0M |
| Q3 2024 | 93 | $192.6M |
| Q2 2024 | 91 | $85.4M |
| Q1 2024 | 117 | $164.3M |
| Q4 2023 | 113 | $154.5M |
| Q3 2023 | 106 | $114.8M |
| Q2 2023 | 118 | $142.7M |
| Q1 2023 | 125 | $148.6M |
| Q4 2022 | 118 | $163.1M |
| Q3 2022 | 138 | $150.3M |
| Q2 2022 | 135 | $157.2M |
| Q1 2022 | 163 | $405.7M |
| Q4 2021 | 162 | $365.9M |
| Q3 2021 | 163 | $499.6M |
| Q2 2021 | 160 | $614.5M |
| Q1 2021 | 152 | $493.1M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Rigel Pharmaceuticals Inc; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −15,303−100.0% | Sold outConverted for a 1-for-10 split |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −8,483−100.0% | Sold outConverted for a 1-for-10 split |
| American International Group, Inc. | 0 | $0 | 0.00% | −8,434−100.0% | Sold outConverted for a 1-for-10 split |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −8,160−100.0% | Sold outConverted for a 1-for-10 split |
| Franklin Resources Inc | 0 | $0 | 0.00% | −7,006−100.0% | Sold outConverted for a 1-for-10 split |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −6,789−100.0% | Sold outConverted for a 1-for-10 split |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −6,182−100.0% | Sold outConverted for a 1-for-10 split |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −4,767−100.0% | Sold outConverted for a 1-for-10 split |
| Providence Wealth Advisors, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold outConverted for a 1-for-10 split |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −3,662−100.0% | Sold outConverted for a 1-for-10 split |
| Stoneridge Investment Partners LLC | 0 | $0 | 0.00% | −3,135−100.0% | Sold outConverted for a 1-for-10 split |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −3,075−100.0% | Sold outConverted for a 1-for-10 split |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −3,048−100.0% | Sold outConverted for a 1-for-10 split |
| LPL Financial LLC | 0 | $0 | 0.00% | −3,022−100.0% | Sold outConverted for a 1-for-10 split |
| Natixis | 0 | $0 | 0.00% | −3,000−100.0% | Sold outConverted for a 1-for-10 split |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −3,000−100.0% | Sold outConverted for a 1-for-10 split |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −2,264−100.0% | Sold outConverted for a 1-for-10 split |
| Brighton Jones LLC | 0 | $0 | 0.00% | −1,900−100.0% | Sold outConverted for a 1-for-10 split |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −1,810−100.0% | Sold outConverted for a 1-for-10 split |
| Fort Point Capital Partners LLC | 0 | $0 | 0.00% | −1,700−100.0% | Sold outConverted for a 1-for-10 split |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −1,276−100.0% | Sold outConverted for a 1-for-10 split |
| Granite Investment Partners, LLC | 0 | $0 | 0.00% | −1,058−100.0% | Sold outConverted for a 1-for-10 split |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −1,016−100.0% | Sold outConverted for a 1-for-10 split |
| Xponance, Inc. | 0 | $0 | 0.00% | −1,012−100.0% | Sold outConverted for a 1-for-10 split |
| Flagship Harbor Advisors, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold outConverted for a 1-for-10 split |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −887−100.0% | Sold outConverted for a 1-for-10 split |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −438−100.0% | Sold outConverted for a 1-for-10 split |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −328−100.0% | Sold outConverted for a 1-for-10 split |
| Continuum Advisory, LLC | 0 | $0 | 0.00% | −58−100.0% | Sold outConverted for a 1-for-10 split |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 0 | $0 | 0.00% | −3−100.0% | Sold outConverted for a 1-for-10 split |